📚 Select Publications

This is an assortment of scientific articles authored or co-authored by our team members, covering real-world evidence in amyotrophic lateral sclerosis (ALS).

• Danielle Boyce – Google Scholar
• Fernando Vieira – Google Scholar

---

• The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
  Imam F, Saloner R, Vogel JW, Krish V, Abdel-Azim G, Ali M, An L, Anastasi F, Bennett D, Pichet Binette A, Boxer AL, Bringmann M, Burns JM, Cruchaga C, Dage JL, Farinas A, Ferrucci L, Finney CA, Frasier M, Hansson O, Hohman TJ, Johnson ECB, Kivimaki M, Korologou-Linden R, Ruiz Laza A, Levey AI, Liepelt-Scarfone I, Lu L, Mattsson-Carlgren N, Middleton LT, Nho K, Oh HS, Petersen RC, Reiman EM, Robinson O, Rothstein JD, Saykin AJ, Shvetcov A, Slawson C, Smets B, Suárez-Calvet M, Tijms BM, Timmers M, Vieira F, Vilor-Tejedor N, Visser PJ, Walker KA, Winchester LM, Wyss-Coray T, Yang C, Bose N, Lovestone S; Global Neurodegeneration Proteomics Consortium (GNPC). Nature Medicine. 2025 Jul 15. doi:10.1038/s41591-025-03834-0. PMID: 40665048

• Free-living monitoring of ALS progression in upper limbs using wearable accelerometers
  Straczkiewicz M, Burke KM, Calcagno N, et al. Journal of NeuroEngineering and Rehabilitation. 2024;21:223. doi:10.1186/s12984-024-01514-7. Full text

• What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology
  Boyce D, Raymond J, Larson TC, Kirkland E, Horton DK, Mehta P. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2024;25(5–6):615–624. doi:10.1080/21678421.2024.2349920. Full text

• Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis
  Gupta AS, Patel S, Premasiri A, Vieira F. medRxiv. 2023. doi:10.1101/2023.03.28.23287869. Preprint

• A machine-learning based objective measure for ALS disease severity
  Vieira FG, Venugopalan S, Premasiri AS, et al. npj Digital Medicine. 2022;5:45. doi:10.1038/s41746-022-00588-8. Full text

---